SCM
Soleus Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-42,400
| Closed | -$2.38M | – | 99 |
|
|
2023
Q2 | $2.38M | Buy |
+42,400
| New | +$2.38M | 0.26% | 70 |
|
|
2023
Q1 | – | Sell |
-22,000
| Closed | -$894K | – | 79 |
|
|
2022
Q4 | $894K | Hold |
22,000
| – | – | 0.13% | 65 |
|
|
2022
Q3 | $1.44M | Hold |
22,000
| – | – | 0.2% | 63 |
|
|
2022
Q2 | $1.34M | Hold |
22,000
| – | – | 0.21% | 63 |
|
|
2022
Q1 | $1.38M | Hold |
22,000
| – | – | 0.18% | 60 |
|
|
2021
Q4 | $1.67M | Sell |
22,000
-70,214
| -76% | -$5.32M | 0.17% | 55 |
|
|
2021
Q3 | $10.3M | Sell |
92,214
-10,900
| -11% | -$1.22M | 1.61% | 18 |
|
|
2021
Q2 | $16.7M | Buy |
+103,114
| New | +$16.7M | 2.57% | 10 |
|
|
2021
Q1 | – | Sell |
-10,825
| Closed | -$1.66M | – | 76 |
|
|
2020
Q4 | $1.66M | Buy |
10,825
+625
| +6% | +$95.7K | 0.22% | 43 |
|
|
2020
Q3 | $853K | Sell |
10,200
-7,000
| -41% | -$585K | 0.45% | 48 |
|
|
2020
Q2 | $1.26M | Buy |
17,200
+800
| +5% | +$58.8K | 0.72% | 33 |
|
|
2020
Q1 | $696K | Sell |
16,400
-5,900
| -26% | -$250K | 0.81% | 29 |
|
|
2019
Q4 | $1.36M | Buy |
+22,300
| New | +$1.36M | 1.31% | 25 |
|